Relationships between quality of life and maintenance therapy in patients with chronic obstructive pulmonary disease
https://doi.org/10.18093/0869-0189-2013-0-4-56-59
Abstract
Summary. Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide resulting in significant everincreasing economic and social burden. Treatment of patients with COPD should take into account clinical characteristics, frequency of exacerbations and quality of life of the patient and the treatment cost. The objective of this study was to evaluate quality of life of patients with COPD 3 stage GOLD with frequent exacerbations receiving different regimens of maintenance therapy. The results showed that in patients with COPD 3 stage GOLD with frequent exacerbations inhaled steroids did not influence on the quality of life and did not have any advantage over combined therapy with long-acting bronchodilators. Further research is needed to estimate the effect of inhaled steroids on frequency of exacerbations.
About the Authors
N. G. MirtskhulavaRussian Federation
K. L. Voenbrand
Russian Federation
A. V. Shvayka
Russian Federation
References
1. Jones P.W., Harding G., Berry P. et al. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34: 648–654.
2. Global Initiative for Chronic Obstructive Lang Disease. Global strategy for the diagnosis management, and prevention of COPD. Updated 2013. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013.pdf
3. Soler J.J., Sanchez L., Latorre M. et al. The impact of COPD on hospital resources the specific burden of COPD patients with high rates of hospitalization. Arch. Bronconeumol. 2001; 37: 375–381.
4. Архипов В.В. Хроническая обструктивная болезнь легких: фармакоэкономические аспекты. Пульмонология 2010; 4: 99–103.
5. Айсанов З.Р., Кальманов Е.Н., Стулова О.Ю. Фенотип хронической обструктивной болезни легких с частыми обострениями и современная противовоспалительная терапия. Пульмонология 2013; 1: 68–75.
6. Авдеев С.Н., Чучалин А.Г. Одышка: механизмы развития, оценка и лечение. Пособие для врачей. М.: Издательство "Медиа Сфера"; 2002. 1–25.
7. Павленко С.С., Павленко Н.С., Куделя Л.М. и др. Исследование эффективности лечения больных хронической обструктивной болезнью легких препаратом Спирива (тиотропия бромид) в Новосибирской области. Пульмонология 2005; 4: 92–96.
8. Зыков К.А., Агапова О.Ю. Комбинированная бронхолитическая терапия у пациентов с хронической обструктивной болезнью легких и сочетанной сердечно-сосудистой патологией. Атмосфера. Пульмонол. и аллергол. 2012; 4: 24–30.
Review
For citations:
Mirtskhulava N.G., Voenbrand K.L., Shvayka A.V. Relationships between quality of life and maintenance therapy in patients with chronic obstructive pulmonary disease. PULMONOLOGIYA. 2013;(4):56-59. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-4-56-59